Kepley BioSystems: Funding, Investors & Team (Sep 2026)
Kepley BioSystems (KBI) is a North Carolina-based life sciences start-up operating out of Gateway University Research Park (GURP) in collaboration with the Joint School of Nanoscience and Nanoengineering (JSNN), comprised of a partnership between the North Carolina Agriculture and Technical State University (NCA&T) and the University of North Carolina at Greensboro (UNCG). KBI was founded in 2013 with a mission to emerge disruptive innovations to achieve global solutions. For more information, visit: http://www.kepleybiosystems.com/
Kepley BioSystems has raised $1.1M across 2 funding rounds on record, the most recent an undisclosed round of $1.0M announced in Dec 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kepley BioSystems Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Kepley BioSystems Funding Rounds
Kepley BioSystems raised $100k in a Grant announced in Mar 2022.
9 months later, an undisclosed round of $1.0M was announced in Dec 2022.
Kepley BioSystems Founders and Leadership Team
No contact details are on record for this team yet.
Kepley BioSystems Funding Compared to Other Biotechnology Startups
Kepley BioSystems' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kepley BioSystems in Biotechnology and Greensboro
Companies Similar to Kepley BioSystems
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Kepley BioSystems Funding FAQs
What does Kepley BioSystems do?
Kepley BioSystems (KBI) is a North Carolina-based life sciences start-up operating out of Gateway University Research Park (GURP) in collaboration with the Joint School of Nanoscience and Nanoengineering (JSNN), comprised of a partnership between the North Carolina Agriculture and Technical State University (NCA&T) and the University of North Carolina at Greensboro (UNCG). KBI was founded in 2013 with a mission to emerge disruptive innovations to achieve global solutions. For more information, visit: http://www.kepleybiosystems.com/
How much funding has Kepley BioSystems raised?
Kepley BioSystems has raised $1.1M across 2 rounds on record. The most recent is an undisclosed round of $1.0M announced in Dec 2022.
When did Kepley BioSystems last raise funding?
Kepley BioSystems' most recent funding round on record is an undisclosed round of $1.0M, announced in Dec 2022.
Who founded Kepley BioSystems?
FundedIQ lists Anthony Dellinger (Founder), Christopher Kepley (Founder) at Kepley BioSystems.
Where is Kepley BioSystems headquartered?
Kepley BioSystems is based in Greensboro, North Carolina, United States.
How many employees does Kepley BioSystems have?
Kepley BioSystems is in the 1-10 employee band.
How does Kepley BioSystems' funding compare to other Biotechnology startups?
Kepley BioSystems' latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Kepley BioSystems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kepley BioSystems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.